Literature DB >> 24399774

The evolution of ways of deciding when clinical trials should stop recruiting. Interview by Iain Chalmers.

Peter Armitage1.   

Abstract

Mesh:

Year:  2014        PMID: 24399774      PMCID: PMC3883153          DOI: 10.1177/0141076813514681

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  15 in total

1.  Statistics and medical experimentation.

Authors:  P Meier
Journal:  Biometrics       Date:  1975-06       Impact factor: 2.571

2.  Comparison of two hypotensive agents; report of a clinical trial.

Authors:  J D ROBERTSON; P ARMITAGE
Journal:  Anaesthesia       Date:  1959-01       Impact factor: 6.955

3.  Value of a large dose of antitoxin in clinical tetanus.

Authors:  A BROWN; S D MOHAMED; R D MONTGOMERY; P ARMITAGE; D R LAURENCE
Journal:  Lancet       Date:  1960-07-30       Impact factor: 79.321

4.  Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium; a controlled trial employing restricted sequential analysis.

Authors:  G WATKINSON
Journal:  Br Med J       Date:  1958-11-01

5.  N-acetylpara-aminophenol as an analgesic; a controlled clinical trial using the method of sequential analysis.

Authors:  D R NEWTON; J M TANNER
Journal:  Br Med J       Date:  1956-11-10

6.  Interim analysis in clinical trials.

Authors:  P Armitage
Journal:  Stat Med       Date:  1991-06       Impact factor: 2.373

7.  Beta-blockade after myocardial infarction--a statistical view.

Authors:  J A Lewis
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

8.  Data and safety monitoring in the Delta trial.

Authors:  P Armitage
Journal:  Control Clin Trials       Date:  1999-06

9.  Controversies and achievements in clinical trials.

Authors:  P Armitage
Journal:  Control Clin Trials       Date:  1984-03

10.  Repeated assessment of results in clinical trials of cancer treatment.

Authors:  J L Haybittle
Journal:  Br J Radiol       Date:  1971-10       Impact factor: 3.039

View more
  1 in total

1.  Trial Sequential Analysis in systematic reviews with meta-analysis.

Authors:  Jørn Wetterslev; Janus Christian Jakobsen; Christian Gluud
Journal:  BMC Med Res Methodol       Date:  2017-03-06       Impact factor: 4.615

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.